Architect of your equity success
Seeking to raise funds or to invest in a healthcare company?
NOVA.SA is the Venture Boutique dedicated to healthcare innovators.
It helps shape Healthcare businesses that deliver lasting value, meaningful returns and increase your probability of success.
It transforms bold ideas into lean, impactful ventures, and guides them through pivotal inflection points, while unlocking breakthrough financial opportunities.
THE NOVA.SA SERVICE PLATFORM
in a few words
NOVA.SA focuses its expertise on healthcare innovations that are scientifically demanding and hard to decode.
It provides a ranges of services in strategy and transaction advisory to accelerate innovation and insure substantial ROI to investors.
Venture builder by DNA
NOVA.SA focuses on biotechnology and healthcare*, leveraging deep sector expertise and a powerful network of cross border investors and collaborators to accelerate transformative projects.
NOVA.SA takes an ecosystem-based approach to overcome the challenges of life science companies. This integrated approach ensures promising ventures move faster from discovery to patient while delivering sustainable returns for shareholders.
Biotechnology and Healthcare
NOVA.SA focuses on companies ranging from seed-stage ventures to growth phases, providing tailored transaction & strategy services to insure smooth transition to later development stage and prepare for M&A and equity success.
From Seed to Growth
NOVA.SA's services are aimed at both founders/ entrepreneurs and investors (limited partners, institutional investors, family offices, club deals, business angels, etc.).
For Healthcare Innovators
*Fields of expertise: Cell & Gene Therapies, In-vivo CAR-T, In-silico Drug Discovery, TechBio, Immunotherapies, Immuno-oncology, Enabling technologies, Class III medical devices, Cardiovascular medical devices, Spine medical devices, Digital Therapeutics
our achievements
(some examples)
Portfolio due diligence of a senescence venture builderDue diligence expert for a Family Office, in the purpose of an investment in a biotech tool companyAssessment report for the board of a synbio company
EXPERT Advisory FOR INVESTORS
Pipeline assessment and asset prioritization, for a regenerative medicine company and a synbio company
Company repurposing from infectiology to oncology
Competition assessment report for an ophtalmology company
STRATEGY ADVISORY FOR STARTUPS
Since creation 2 years ago, involved in 20M$ secured transactions and the reception of 3 LOIs
Transaction advisory
WHY IT WORKS
Capture the business case’s
big picture
TAKE A PROACTIVE APPROACH
MAKE THE BEST DECISIONS
Objectively reinforce your convictions
Ready to start?
A simple request, and we move on to the next step